Consults for numerous pharmaceutical companies on the methods for stabilizing and characterizing solid pharmaceuticals. Has developed a new compound, Cosalane, capable of intercepting the HIV virus before it attaches to a host cell. Cosalane is undergoing preclinical development.
Expertise includes knowledge of flu viruses.
Has written for newspapers and worked with television in these areas. Member of American Society of Microbiology, American Society of Virology, and International Society for Interferon and Cytokine Research. Expertise in areas of viruses and immunology. Research focuses on how antibodies kill viruses and the structure of various viral components. Also using crystallography with electron microscopy to probe the structure of several togaviruses, a family of viruses responsible for several tropical diseases, such as yellow fever and dengue.